Management of severe systemic infections caused by multiple resistant organisms

Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort.

European journal of medical research·2009

Inhibition of TNF-alpha mediated cell death by HIV-1 specific protease inhibitors.

European journal of medical research·2003

Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).

Leukemia & lymphoma·2001

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load.

AIDS (London, England)·2000

Case report. Successful therapy of disseminated histoplasmosis in AIDS with liposomal amphotericin B.

Mycoses·1999

Virological response to protease inhibitor therapy in an HIV clinic cohort.

AIDS (London, England)·1999

Effectiveness of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in people with HIV with very high viral load (≥500 000 copies/mL).

The Journal of antimicrobial chemotherapy·2026

Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment.

The Journal of antimicrobial chemotherapy·2026

Antimicrobial-loaded PMMA bone cement: time for good practice recommendations.

The Journal of antimicrobial chemotherapy·2026

Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis.

The Journal of antimicrobial chemotherapy·2026

Performance of plasma separation cards for HIV drug-resistance genotyping in a resource-limited setting: comparison with plasma samples.

The Journal of antimicrobial chemotherapy·2026

Antibiotic consumption in HIV and PrEP populations with and without sexually transmitted infections: a population-based observational study.

The Journal of antimicrobial chemotherapy·2026

Mechanisms of action of the hexane extract of Hypericum brasiliense and its component uliginosin B against drug-resistant Staphylococcus aureus.

ADMET & DMPK·2026

Differential Roles of Ag and ZnO in the Bactericidal Activity of Ag/ZnO-Hydroxyapatite Nanocomposites against Multidrug-Associated Methicillin-Resistant Staphylococcus aureus.

Current microbiology·2026

Recurrent intraocular inflammation: Staphylococcus hominis endophthalmitis.

Archivos de la Sociedad Espanola de Oftalmologia·2026

Early sputum bacterial load dynamics predict treatment response in multidrug-resistant/rifampicin-resistant tuberculosis: a multicenter prospective cohort study.

The Journal of infection·2026

Morpho-molecular approach reveals a myco-endophyte, Aspergillus novoparasiticus CBS126849 (MTCC-13997) from the roots of Capparis decidua with therapeutic and enzymatic potential.

Archives of microbiology·2026

Evaluation of phage-antibiotic combinations in the inactivation of urinary tract infection-related bacteria.

Journal of applied microbiology·2026

Related Experiment Videos

Management of severe systemic infections caused by multiple resistant organisms

Related Concept Videos

Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort.

Inhibition of TNF-alpha mediated cell death by HIV-1 specific protease inhibitors.

Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load.

Case report. Successful therapy of disseminated histoplasmosis in AIDS with liposomal amphotericin B.

Virological response to protease inhibitor therapy in an HIV clinic cohort.

Effectiveness of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in people with HIV with very high viral load (≥500 000 copies/mL).

Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment.

Antimicrobial-loaded PMMA bone cement: time for good practice recommendations.

Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis.

Performance of plasma separation cards for HIV drug-resistance genotyping in a resource-limited setting: comparison with plasma samples.

Antibiotic consumption in HIV and PrEP populations with and without sexually transmitted infections: a population-based observational study.

Mechanisms of action of the hexane extract of Hypericum brasiliense and its component uliginosin B against drug-resistant Staphylococcus aureus.

Differential Roles of Ag and ZnO in the Bactericidal Activity of Ag/ZnO-Hydroxyapatite Nanocomposites against Multidrug-Associated Methicillin-Resistant Staphylococcus aureus.

Recurrent intraocular inflammation: Staphylococcus hominis endophthalmitis.

Early sputum bacterial load dynamics predict treatment response in multidrug-resistant/rifampicin-resistant tuberculosis: a multicenter prospective cohort study.

Morpho-molecular approach reveals a myco-endophyte, Aspergillus novoparasiticus CBS126849 (MTCC-13997) from the roots of Capparis decidua with therapeutic and enzymatic potential.

Evaluation of phage-antibiotic combinations in the inactivation of urinary tract infection-related bacteria.

Related Experiment Videos

Management of severe systemic infections caused by multiple resistant organisms

Related Concept Videos

Related Articles